These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33646139)

  • 1. Use of bioimpedance spectroscopy for prospective surveillance and early diagnosis of breast cancer-related lymphedema.
    Forte AJ; Huayllani MT; Boczar D; Avila FR; Kassis S; Ciudad P; Lu X; Moore PA; McLaughlin SA
    Breast Dis; 2021; 40(2):85-93. PubMed ID: 33646139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioimpedance Spectroscopy for Assessment of Breast Cancer-Related Lymphedema: A Systematic Review.
    Forte AJ; Huayllani MT; Boczar D; Ciudad P; Lu X; Kassis S; Parker AS; Moore PA; McLaughlin SA
    Plast Surg Nurs; 2020; 40(2):86-90. PubMed ID: 32459756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.
    Shah C; Whitworth P; Valente S; Schwarz GS; Kruse M; Kohli M; Brownson K; Lawson L; Dupree B; Vicini FA
    Breast Cancer Res Treat; 2023 Feb; 198(1):1-9. PubMed ID: 36566297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy.
    Whitworth PW; Cooper A
    Breast J; 2018 Jan; 24(1):62-65. PubMed ID: 29063664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer-Related Lymphedema (BCRL) and Bioimpedance Spectroscopy: Long-Term Follow-Up, Surveillance Recommendations, and Multidisciplinary Risk Factors.
    Jeffers EJ; Wagner JL; Korentager SS; Larson KE; Balanoff CR; Baker J; Chollet-Hinton L; Kilgore LJ
    Ann Surg Oncol; 2023 Oct; 30(10):6258-6265. PubMed ID: 37535267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of perometry-based volumetric arm measurements and bioimpedance spectroscopy for early identification of lymphedema in a prospectively-screened cohort of breast cancer patients.
    Gillespie TC; Roberts SA; Brunelle CL; Bucci LK; Bernstein MC; Daniell KM; Naoum GN; Miller CL; Taghian AG
    Lymphology; 2021; 54(1):1-11. PubMed ID: 34506083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.
    Shah C; Zambelli-Weiner A; Delgado N; Sier A; Bauserman R; Nelms J
    Breast Cancer Res Treat; 2021 Feb; 185(3):709-740. PubMed ID: 33245458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema.
    Vicini F; Shah C; Whitworth P; Walker M; Shi J
    Lymphat Res Biol; 2018 Dec; 16(6):533-537. PubMed ID: 30133336
    [No Abstract]   [Full Text] [Related]  

  • 9. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
    Kaufman DI; Shah C; Vicini FA; Rizzi M
    Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
    Kilgore LJ; Korentager SS; Hangge AN; Amin AL; Balanoff CR; Larson KE; Mitchell MP; Chen JG; Burgen E; Khan QJ; O'Dea AP; Nye L; Sharma P; Wagner JL
    Ann Surg Oncol; 2018 Oct; 25(10):2948-2952. PubMed ID: 29987599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Diagnostic Tools for Breast Cancer-Related Lymphedema.
    Shah C; Asha W; Vicini F
    Curr Oncol Rep; 2023 Mar; 25(3):151-154. PubMed ID: 36696076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing rates of chronic breast cancer-related lymphedema with screening and early intervention: an update of recent data.
    Whitworth P; Vicini F; Valente SA; Brownson K; DuPree B; Kohli M; Lawson L; Shah C
    J Cancer Surviv; 2024 Apr; 18(2):344-351. PubMed ID: 35947288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is bioimpedance spectroscopy a useful tool for objectively assessing lymphovenous bypass surgical outcomes in breast cancer-related lymphedema?
    Sutherland A; Wagner JL; Korentager S; Butterworth J; Amin AL; Balanoff CR; Hangge A; Larson KE
    Breast Cancer Res Treat; 2021 Feb; 186(1):1-6. PubMed ID: 33392840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining breast cancer-related lymphedema (BCRL) prevalence and risk factors: A pragmatic approach to lymphedema surveillance.
    Hing JX; Chua YN; Tan PT; Tan MSL; Mok CW; Seet MYL; Lin ZC; Seah CM; Lee WP; Tan SM
    Ann Acad Med Singap; 2024 Feb; 53(2):80-89. PubMed ID: 38920232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioimpedance Spectroscopy for Breast Cancer Related Lymphedema Assessment: Clinical Practice Guidelines.
    Shah C; Vicini FA; Arthur D
    Breast J; 2016 Nov; 22(6):645-650. PubMed ID: 27487985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Early Detection of Breast Cancer Treatment-Related Lymphedema of the Arm.
    Keeley V
    Lymphat Res Biol; 2021 Feb; 19(1):51-55. PubMed ID: 33270493
    [No Abstract]   [Full Text] [Related]  

  • 17. Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.
    Lim SM; Han Y; Kim SI; Park HS
    BMC Cancer; 2019 Jul; 19(1):669. PubMed ID: 31286884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention.
    Ridner SH; Dietrich MS; Boyages J; Koelmeyer L; Elder E; Hughes TM; French J; Ngui N; Hsu J; Abramson VG; Moore A; Shah C
    Lymphat Res Biol; 2022 Dec; 20(6):618-628. PubMed ID: 35099283
    [No Abstract]   [Full Text] [Related]  

  • 19. A comprehensive review of bioimpedance spectroscopy as a diagnostic tool for the detection and measurement of breast cancer-related lymphedema.
    Seward C; Skolny M; Brunelle C; Asdourian M; Salama L; Taghian AG
    J Surg Oncol; 2016 Oct; 114(5):537-542. PubMed ID: 27393376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Surveillance with Compression for Subclinical Lymphedema: Symptoms, Skin, and Quality-of-Life Outcomes.
    Dietrich MS; Gaitatzis K; Koelmeyer L; Boyages J; Abramson VG; McLaughlin SA; Ngui N; Elder E; French J; Hsu J; Hughes TM; Stolldorf DP; Shah C; Ridner SH
    Lymphat Res Biol; 2023 Jun; 21(3):304-313. PubMed ID: 36126315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.